Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference
January 02 2019 - 4:05PM
Novavax to Present at the 37th Annual J.P. Morgan Healthcare
Conference
Novavax, Inc. (Nasdaq:NVAX) today announced that it will present at
the 37th Annual J.P. Morgan Healthcare Conference.
Presentation details are as follows:
Date and time: Wednesday,
January 9, 3:00 p.m. – 3:25 p.m. P.T.Location:
Colonial Room, Westin St. Francis Hotel, San FranciscoLive
webcast: www.novavax.com, “Investors”/“Events”
A replay of the presentation will also be
accessible under the “Investors/Events” section of the website at
www.novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a late-stage
biotechnology company that drives improved health globally through
the discovery, development, and commercialization of innovative
vaccines to prevent serious infectious diseases. ResVax™, its RSV
vaccine for infants via maternal immunization, is the only vaccine
in a Phase 3 clinical program and is designed to prevent the second
leading cause of death in children under one year of age worldwide.
Novavax is also advancing NanoFlu™, its quadrivalent influenza
nanoparticle vaccine, to address key factors that can lead to the
poor effectiveness of currently approved flu vaccines. Novavax is a
leading innovator of recombinant vaccines; its proprietary
recombinant technology platform combines the power and speed of
genetic engineering to efficiently produce a new class of highly
immunogenic nanoparticles addressing urgent global health
needs.
For more information, visit www.novavax.com and
connect with us on Twitter and LinkedIn.
Contacts:
InvestorsNovavax, Inc.Erika Trahanir@novavax.com240-268-2000
Westwicke PartnersJohn
Woolfordjohn.woolford@westwicke.com443-213-0506
MediaSam BrownAndrea
Cohenandreacohen@sambrown.com917-209-7163
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From May 2023 to May 2024